OTCQX:MRVFF - Post by User
Comment by
lscfaon Jan 29, 2021 10:43am
191 Views
Post# 32419801
RE:RE:Valuation
RE:RE:Valuation another comparison....
| Q3 2020 | Nuvo | Medexus |
| Cash flow ops | 5,160 | 2,263 |
| Ave Shs o/s | 11,388 | 14,454 |
| Qtrly cfps | $0.453 | $0.157 |
| Annual cfps | $1.81 | $0.63 |
| Sh pr | $2.50 | $7.75 |
| Multiple | 1.38 | 12.38 |
lscfa wrote:
Corrected table.....
| | Nuvo | Nuvo | Medexus |
| 2021 ebitda | 22.6 | 22.6 | 15.1 |
| Multiple | 6.5 | 11.0 | 11 |
| Ent value | 146.9 | 248.6 | 166.1 |
| Net debt | 115.6 | 115.6 | 54.6 |
| Mkt cap | 31.3 | 133.0 | 111.5 |
| Shs o/s | 11.4 | 11.4 | 14.5 |
| Share value | $2.75 | $11.67 | $7.69 |
lscfa wrote: Still cheaper than peers../
| | Nuvo | Nuvo | Medexus |
| 2021 ebitda | 22.6 | 22.6 | 15.1 |
| Multiple | 6.5 | 11.0 | 11 |
| Ent value | 146.9 | 248.6 | 166.1 |
| Net debt | 115.6 | 115.6 | 54.6 |
| Mkt cap | 31.3 | 133.0 | 111.5 |
| Shs o/s | 11.4 | 40.0 | 14.5 |
| Share value | $2.75 | $3.33 | $7.69 |